MV Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
MV Capital Management's RARE Position: Q3 2026 in Review
MV Capital Management sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 19 shares — an estimated $635 sold.
MV Capital Management first reported a position in RARE in Q1 2024 and held it in 10 quarters. The position peaked at $2.05K in Q3 2025. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- MV Capital Management reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- MV Capital Management sold 19 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $635.
- MV Capital Management first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and held it in 10 quarters.
- MV Capital Management's Ultragenyx Pharmaceutical position peaked at $2.05K in Q3 2025.
- 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.